al7bebe
عضو نشط
- التسجيل
- 24 مارس 2005
- المشاركات
- 10,052
دورة المؤشرنت للتحليل الفني
50 دينار كويتي
ترقبوووو Gnta بالغد
- بادئ الموضوع العتر
- تاريخ البدء
al7bebe
عضو نشط
- التسجيل
- 24 مارس 2005
- المشاركات
- 10,052
Day's Range: 0.92 - 1.50
http://biz.yahoo.com/prnews/070905/nyw050.html?.v=101
Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Wednesday September 5, 8:00 am ET
Barcelona Hosts Key Investigator Meeting for European Participants in Phase 3 AGENDA Trial Targeting Biomarker-Defined Population
BERKELEY HEIGHTS, N.J., Sept. 5 /PRNewswire-FirstCall/ - Genta Incorporated (Nasdaq: GNTA - News) announced that data from the Company's Phase 3 trial of Genasense® (oblimersen sodium) plus chemotherapy would be presented at the opening session of the first Worldwide Melanoma Center Meeting organized by the European Association of Dermato-Oncology (EADO). Genta, which is a Silver Level sponsor of the EADO meeting, will also host its key investigator meeting for European participants in the Company's ongoing Phase 3 trial of Genasense in advanced melanoma. The Genasense clinical results will be presented by Dr. Claus Garbe, who is Chair of the Congress, and Professor of Dermatology and Head of the Division of Dermatooncology, Department of Dermatology, University Medical Center, Tubingen, Germany. The EADO, which is the lead international cooperative group for the current Phase 3 trial, is meeting this week in Barcelona, Spain.
http://biz.yahoo.com/prnews/070905/nyw050.html?.v=101
Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Wednesday September 5, 8:00 am ET
Barcelona Hosts Key Investigator Meeting for European Participants in Phase 3 AGENDA Trial Targeting Biomarker-Defined Population
BERKELEY HEIGHTS, N.J., Sept. 5 /PRNewswire-FirstCall/ - Genta Incorporated (Nasdaq: GNTA - News) announced that data from the Company's Phase 3 trial of Genasense® (oblimersen sodium) plus chemotherapy would be presented at the opening session of the first Worldwide Melanoma Center Meeting organized by the European Association of Dermato-Oncology (EADO). Genta, which is a Silver Level sponsor of the EADO meeting, will also host its key investigator meeting for European participants in the Company's ongoing Phase 3 trial of Genasense in advanced melanoma. The Genasense clinical results will be presented by Dr. Claus Garbe, who is Chair of the Congress, and Professor of Dermatology and Head of the Division of Dermatooncology, Department of Dermatology, University Medical Center, Tubingen, Germany. The EADO, which is the lead international cooperative group for the current Phase 3 trial, is meeting this week in Barcelona, Spain.
al7bebe
عضو نشط
- التسجيل
- 24 مارس 2005
- المشاركات
- 10,052
Bokandar79
عضو نشط
منت سهل يالحبيب...
تخمر على وايد شغلات حلوه وتسكت عنها...
آه منك,,,
عسى الله يوفقك ياخوي...
q879
عضو نشط
- التسجيل
- 7 أبريل 2007
- المشاركات
- 69
ممكن أترجمون الخبر
Bokandar79
عضو نشط
الله يوفقك ويرزقك ويعافيك يالعسل
q879
عضو نشط
- التسجيل
- 7 أبريل 2007
- المشاركات
- 69
جزاك الله خير والله يبعد عن الامراض يعني الخبر هذا اثر على السهم وارفع ولا في شيء ثاني
Bokandar79
عضو نشط
اجمعين يارب
حبيب يالزعيم ماقصرت
جزاك الله خير والله يبعد عن الامراض يعني الخبر هذا اثر على السهم وارفع ولا في شيء ثاني
الخبر ايجابي وان شاء الله خير...
بس الحذر.. الشركه سوف تقدم ابحاث عن دواء واذا (الله لايقوله) افشلة بتقديم الدواء سوف ترا الشركه بالقااااااع...
خل عينك عالاخبار @@
واذا في اي شي جديد سوف اقدمه لك ان شاء الله..
بالتوفيج ياخوي..
Bokandar79
عضو نشط
كان مرتفع 16%
ملاحظ جيد...
ارتفاع اليوم اكثر من 40%
ان شاء الله تشوفونه بالايام القادمه بالعلالي
بس يبيله شوية صبر واخبار طيبه,,,بالتوفيج..
دورة المؤشرنت للتحليل الفني
50 دينار كويتي